IGC Pharma IGC Ratios (2010-2026)

NYSE IGC
$0.27 +0.00 (+0.30%)
As of: Sep 30, 2026 · 3:59 PM EDT
Reported Financials

IGC Pharma Quarterly Ratios

Periods 64 quarters
Latest Mar 2026

IGC Pharma reported a gross margin of 17.35% and a net margin of -757.73% for the quarter ended Mar 2026. These financial ratios cover 64 quarters of results from Jun 2010 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin
33.77%67.86%43.66%55.74%66.98%66.83%30.72%37.95%45.95%59.79%65.20%57.97%59.93%48.06%40.47%46.67%46.95%51.83%17.35%
EBT Margin
-2,322.08%-7,757.14%-1,676.76%-5,330.33%-1,313.68%-1,208.91%-677.41%-2,427.71%-373.87%-842.27%-2,739.71%-977.97%-874.26%-416.75%-711.67%-363.03%-487.50%-953.40%-757.73%
EBIT Margin
-2,849.35%-7,764.29%-1,679.58%-5,328.69%-1,321.70%-1,231.68%-686.14%-2,433.13%-385.41%-856.01%-1,469.61%-735.59%-880.88%-427.18%-730.74%-428.18%-580.79%-1,517.80%-775.39%
EBITDA Margin
-2,645.45%-7,473.21%-1,562.68%-5,193.44%-1,245.28%-1,147.52%-634.34%-2,340.96%-357.48%-801.72%-1,391.18%-680.00%-821.32%-391.99%-669.65%-381.52%-537.80%-1,455.50%-757.10%
Operating Margin
-2,849.35%-7,764.29%-1,679.58%-5,328.69%-1,321.70%-1,231.68%-686.14%-2,433.13%-385.41%-856.01%-1,469.61%-735.59%-880.88%-427.18%-730.74%-428.18%-580.79%-1,517.80%-775.39%
Net Margin
-2,322.08%-7,757.14%-1,676.76%-5,330.33%-1,313.68%-1,208.91%-677.41%-2,427.71%-373.87%-842.27%-2,739.71%-977.97%-874.26%-416.75%-711.67%-363.03%-487.50%-953.40%-757.73%
FCF Margin
-2,524.68%-4,167.86%-1,724.65%-795.90%-1,095.75%-634.65%-671.69%-916.87%-268.11%-568.04%-811.27%-183.39%-658.09%-248.79%-522.96%-226.67%-431.40%-1,109.42%-386.12%
Efficiency
Inventory AverageInventory Avg.
5.48M5.49M5.46M4.49M3.58M3.69M3.75M3.20M2.65M2.64M2.28M1.73M1.52M1.51M1.47M1.40M1.35M1.00M0.65M0.64M
Assets AverageAssets Avg.
35.16M34.14M32.56M29.06M25.50M23.06M21.01M18.62M16.43M16.09M13.88M10.58M10.25M10.48M9.72M8.91M8.35M8.84M9.73M9.45M
Equity AverageEquity Avg.
32.27M31.50M30.37M26.68M22.97M21.09M19.23M16.61M14.06M13.65M11.58M8.19M7.60M7.63M6.82M6.29M6.20M7.08M7.76M6.77M
Invested CapitalInvested Cap.
31.89M31.41M29.62M24.04M22.19M20.29M18.46M15.05M13.34M14.24M9.19M7.46M8.02M7.51M6.39M6.46M6.21M8.22M7.91M7.76M
Asset Utilization RatioAsset Util.
0.010.010.010.010.020.030.040.050.080.080.090.130.100.110.130.140.160.130.12
Leverage & Solvency
Interest Coverage RatioInterest Cover
Debt Ratio
0.000.000.000.010.010.010.010.010.010.010.010.010.010.010.010.020.020.010.050.18
Times Interest Earned
Valuation
Price to SalesP/S
202.52234.60140.54122.1751.6533.6519.5719.7913.1117.0614.6819.8330.6227.8621.5117.8219.6634.9222.03
Price to BookP/B
2.502.421.702.031.251.130.931.211.251.631.973.644.134.474.253.584.294.773.474.20
Enterprise Value
65.87M61.14M38.09M38.04M19.42M16.00M11.95M14.69M14.50M19.81M16.47M25.48M30.70M31.41M26.12M22.24M25.63M37.49M24.81M25.45M
Market Capitalization
79.19M75.54M50.03M48.50M27.48M22.81M16.98M18.05M16.45M22.93M17.85M26.68M32.52M32.95M26.59M22.65M26.08M38.62M25.75M25.69M
Price to FCFP/FCF
EV to FCF
EV to CFO
Return Ratios
Return on Sales [ROS]ROS
-2,849.35%-7,764.29%-1,679.58%-5,328.69%-1,321.70%-1,231.68%-686.14%-2,433.13%-385.41%-856.01%-1,469.61%-735.59%-880.88%-427.18%-730.74%-428.18%-580.79%-1,517.80%-775.39%
Return on Capital Employed [ROCE]ROCE
-27.20%-36.29%-37.46%-57.96%-67.26%-65.39%-71.57%-69.39%-76.56%-78.29%-97.66%-118.90%-129.59%-121.41%-116.10%-111.89%-105.08%-110.45%-131.93%
Return on Invested Capital [ROIC]ROIC
Return on Assets [ROA]ROA
-24.80%-33.40%-35.20%-51.67%-62.80%-61.19%-66.52%-61.78%-65.73%-67.16%-101.89%-122.87%-129.81%-119.92%-90.59%-79.91%-76.01%-72.91%-74.30%
Return on Equity [ROE]ROE
-27.01%-36.21%-37.75%-56.27%-69.72%-66.90%-72.69%-69.25%-76.80%-79.16%-122.20%-158.79%-175.03%-164.76%-129.20%-113.15%-102.24%-91.00%-103.66%

IGC Pharma Ratios API

Pull IGC Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IGC&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY